Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 7
1981 6
1982 7
1983 10
1984 8
1985 6
1986 7
1987 2
1988 4
1989 2
1990 1
1991 3
1993 1
1994 3
1995 8
1996 7
1997 3
1998 8
1999 7
2000 2
2001 11
2002 8
2003 7
2004 9
2005 10
2006 9
2007 6
2008 13
2009 26
2010 30
2011 20
2012 20
2013 11
2014 16
2015 18
2016 20
2017 11
2018 7
2019 8
2020 9
2021 10
2022 10
2023 8
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Fenofibric acid for hyperlipidemia.
Saurav A, Kaushik M, Mohiuddin SM. Saurav A, et al. Expert Opin Pharmacother. 2012 Apr;13(5):717-22. doi: 10.1517/14656566.2012.658774. Epub 2012 Mar 9. Expert Opin Pharmacother. 2012. PMID: 22404421 Review.
AREAS COVERED: This article reviews the role of fenofibric acid in the context of results from recent randomized trials on fenofibrate, including the ACCORD Trial. It discusses the current status of fenofibric acid in the management of dyslipidemia, es …
AREAS COVERED: This article reviews the role of fenofibric acid in the context of results from recent randomized trials on fen …
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Wiggins BS, Saseen JJ, Page RL 2nd, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology. Wiggins BS, et al. Circulation. 2016 Nov 22;134(21):e468-e495. doi: 10.1161/CIR.0000000000000456. Epub 2016 Oct 17. Circulation. 2016. PMID: 27754879 Review. No abstract available.
Lipid-lowering drugs.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. Med Lett Drugs Ther. 2019. PMID: 30845106 No abstract available.
In Situ Vaccination with Mitochondria-Targeting Immunogenic Death Inducer Elicits CD8+ T Cell-Dependent Antitumor Immunity to Boost Tumor Immunotherapy.
Wang Y, Wang W, Gu R, Chen J, Chen Q, Lin T, Wu J, Hu Y, Yuan A. Wang Y, et al. Adv Sci (Weinh). 2023 Jul;10(20):e2300286. doi: 10.1002/advs.202300286. Epub 2023 May 1. Adv Sci (Weinh). 2023. PMID: 37127892 Free PMC article.
Herein, an immunogenic cell death (ICD) inducer for in situ vaccination, which is based on a mitochondria-targeting modification of fenofibric acid (FFa), a lipid-lowering drug with potential inhibitory efficacy of respiratory complex I is developed. ...
Herein, an immunogenic cell death (ICD) inducer for in situ vaccination, which is based on a mitochondria-targeting modification of fenof …
In vitro metabolism of fenofibric acid by carbonyl reducing enzymes.
Malátková P, Kanavi M, Nobilis M, Wsól V. Malátková P, et al. Chem Biol Interact. 2016 Oct 25;258:153-8. doi: 10.1016/j.cbi.2016.09.001. Epub 2016 Sep 4. Chem Biol Interact. 2016. PMID: 27599626
Fenofibric acid is a hypolipidemic drug that is used as an active ingredient per se or is administered in the form of fenofibrate that releases fenofibric acid after absorption. The metabolism of fenofibric acid is mediated primarily by g …
Fenofibric acid is a hypolipidemic drug that is used as an active ingredient per se or is administered in the form of fenofibr …
Update on fenofibrate.
Guay DR. Guay DR. Cardiovasc Drug Rev. 2002 Winter;20(4):281-302. doi: 10.1111/j.1527-3466.2002.tb00098.x. Cardiovasc Drug Rev. 2002. PMID: 12481201 Review.
Fenofibrate is a fibric acid derivative that has been marketed since the mid-1970's (1998 in the United States). Its active metabolite, fenofibric acid, is responsible for the primary pharmacodynamic effects of the drug: reductions in total plasma cholesterol, low d …
Fenofibrate is a fibric acid derivative that has been marketed since the mid-1970's (1998 in the United States). Its active metabolite, f …
Fenofibric Acid (trilipix).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 May 4;51(1311):33-4. Med Lett Drugs Ther. 2009. PMID: 19417718 No abstract available.
Effects of fenofibric acid on diabetic macular edema: the MacuFen study.
Massin P, Peto T, Ansquer JC, Aubonnet P, MacuFEN Study Investigators FT. Massin P, et al. Ophthalmic Epidemiol. 2014 Oct;21(5):307-17. doi: 10.3109/09286586.2014.949783. Epub 2014 Aug 18. Ophthalmic Epidemiol. 2014. PMID: 25133794 Clinical Trial.
Weighted inner zone thickness and volume decreased by -18.7 m and -0.13 mm(3), respectively, for within group difference after fenofibric acid and by -3.1 m and -0.02 mm(3), respectively, after placebo. Considering all eligible eyes, thicknesses at central zone, mea …
Weighted inner zone thickness and volume decreased by -18.7 m and -0.13 mm(3), respectively, for within group difference after fenofibric …
Fenofibric Acid Can Cause False-Positive Urine Methylenedioxymethamphetamine Immunoassay Results.
Quesada L, Gomila I, Fe A, Servera MA, Yates C, Morell-Garcia D, Castanyer B, Barceló B. Quesada L, et al. J Anal Toxicol. 2015 Nov-Dec;39(9):734-40. doi: 10.1093/jat/bkv074. Epub 2015 Jul 22. J Anal Toxicol. 2015. PMID: 26203185
We estimated that the addition of 225 g/mL pure fenofibric acid to blank urine would be sufficient to result in a positive DRI() Ecstasy Assay. ...This apparent discrepancy can be explained in several ways, one of them is that the beta-glucuronidase-resistent fen …
We estimated that the addition of 225 g/mL pure fenofibric acid to blank urine would be sufficient to result in a positive DRI …
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia.
Alagona P Jr. Alagona P Jr. Vasc Health Risk Manag. 2010 May 25;6:351-62. doi: 10.2147/vhrm.s6714. Vasc Health Risk Manag. 2010. PMID: 20531954 Free PMC article. Review.
We will review a new agent, TriLipix((R)) (fenofibric acid), and its potential role in treatment....
We will review a new agent, TriLipix((R)) (fenofibric acid), and its potential role in treatment....
376 results